Explore
Trendline
Passkey Therapeutics Appoints New CMO to Lead Drug Combination Platform
Passkey Therapeutics Appoints New CMO to Lead Drug Combination Platform
Read More
Trendline
Vistagen Appoints Angel S. Angelov as Chief Medical Officer to Enhance Neurocircuitry Research
Vistagen Appoints Angel S. Angelov as Chief Medical Officer to Enhance Neurocircuitry Research
Read More
Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth
Read More
Trendline
Harbour BioMed Advances AI-Enabled Drug Candidate LET003 for Obesity Treatment
Harbour BioMed Advances AI-Enabled Drug Candidate LET003 for Obesity Treatment
Read More
Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Drive Growth
ATB Therapeutics Appoints Mark Throsby as CEO to Drive Growth
Read More
Trendline
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead
Read More
Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase
Read More
Trendline
Akari Therapeutics Reports Increased Net Loss in Q1 2026 Amid Pre-Revenue Status
Akari Therapeutics Reports Increased Net Loss in Q1 2026 Amid Pre-Revenue Status
Read More
Trendline
Regeneron and Parabilis Collaborate to Develop New Drug Class Targeting Undruggable Proteins
Regeneron and Parabilis Collaborate to Develop New Drug Class Targeting Undruggable Proteins
Read More
Trendline
Vistagen Appoints Angel S. Angelov as Chief Medical Officer to Enhance Neurocircuitry Product Development
Vistagen Appoints Angel S. Angelov as Chief Medical Officer to Enhance Neurocircuitry Product Development
Read More
Trendline
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy
Read More
Trendline
Parabilis Medicines and Regeneron Pharmaceuticals Collaborate on Novel Therapeutics
Parabilis Medicines and Regeneron Pharmaceuticals Collaborate on Novel Therapeutics
Read More
